Bud BilanichSuccess Coach
Suma Ramadas, PhDMedical Affairs
Brenda SnowAuthentic Patient Voice
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Matthew DurhamOmnidynamic Marketing
Matt TurnerPatient Affordability
Liz KaneImpactful Strategy
Daniel SontupeMarket Access
Amy GilesIncreasing Engagement
Pat PurcellMeeting Engagement
Joey CohenMedication Adherence
ZEJULA is the first PARP inhibitor approved in Europe for women with recurrent ovarian ...
CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email